On the BRINK: PhotoBiomodulation (PBM) for Mucositis in Patients Undergoing Allogeneic Hematopoietic Stem Cell TRansplant (HSCT) - Implementing the Evidence & Discovering New Knowledge

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

6 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-10-07

Study Completion Date

2025-12-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study evaluates mucositis and other oral symptoms in patients undergoing photobiomodulation in patients undergoing hematopoietic stem cell transplantation.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effectiveness of Extraoral Photobiomodulation in Management of Oral Adverse Effects in Patients Undergoing HSCT

NCT05759975

Oral Mucositis Hematopoietic Neoplasm Xerostomia +1 more

UNKNOWN NA

Prevention of Oral Mucositis Using Photobiomodulation Therapy

NCT04227340

Oral Mucositis

COMPLETED NA

Interest of Light Therapy in Hematology - The PHOTO-TREAT Study

NCT06326268

Leukemia, Myeloid, Acute Lymphoma

RECRUITING NA

Laser Therapy in Preventing Oral Mucositis in Patients Undergoing Bone Marrow Transplantation

NCT00024037

Oral Complications

COMPLETED PHASE2/PHASE3

Incidence and Factors Associated With the Development and Severity of Oral Mucositis

NCT00575809

Peripheral Blood Stem Cell Transplantation

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

PRIMARY OBJECTIVE:

I. Examine mucositis severity, oral pain, taste changes, and xerostomia in patients undergoing PBM, a new standard of care for oral mucositis.

OUTLINE: This is an observational study. Participants are assigned to 1 of 2 groups.

GROUP I: Patients have their medical records reviewed on study.

GROUP II: Nurses complete surveys on study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hematopoietic and Lymphatic System Neoplasm Malignant Solid Neoplasm

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group I (Patients)

Patients have their medical records reviewed on study.

Non-Interventional Study

Intervention Type OTHER

Non-interventional study

Group II (Nurses)

Nurses complete surveys on study.

Non-Interventional Study

Intervention Type OTHER

Non-interventional study

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Non-Interventional Study

Non-interventional study

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* PATIENTS:

* Age: ≥ 18 years
* Undergoing allogeneic HSCT - cases where PBM was used and cases where PBM was not used

NURSES:

* Nurses who administer PBM

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes